880.6000 -19.20 (-2.13%)
NSE Dec 08, 2025 15:31 PM
Volume: 141.7K
 

logo
Alembic Pharmaceuticals Ltd.
07 May 2025, 12:00AM
880.60
-2.13%
BOB Capital Markets Ltd.
Revenue/EBITDA/ PAT grew 6.7%/8% and 19% above our estimates. EBITDA margin reported 20bps above estimates of 15.4% in 4QFY25
Alembic Pharmaceutic.. has an average target of 1028.50 from 4 brokers.
More from Alembic Pharmaceuticals Ltd.
Recommended